SREBF1 and breast carcinoma: Prior studies in hepatocellular and breast cancers show that IGF2BP3 (IMP3) binds the 3′ UTR of SREBP1c mRNA, stabilizing the transcript and enhancing SREBP1c nuclear accumulation and transactivation of lipogenic targets, including FASN [36,37].